N-methyl-3-phenylbutanamide | 96013-67-1

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: N-methyl-3-phenylbutanamide
• CAS: 96013-67-1
• 化学式: C₁₁H₁₅NO
• mdl: MFCD03348263
• 分子量: 177.246
• InChiKey: SPSRNBYKWRFJRB-UHFFFAOYSA-N

物化性质

• 沸点：
  339.8±21.0 °C(Predicted)
• 密度：
  0.993±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-methyl-3-phenylbutanamide 生成 (R)-N-methyl-3-phenylbutanamide 、 (S)-3-phenyl-N-methylbutanamide
  参考文献：
  名称：

  Investigation of a broadly applicable chiral selector used in enantioselective chromatography (Whelk-O 1) as a chiral solvating agent for NMR determination of enantiomeric composition

  摘要：

  A chiral solvating agent (CSA) based on the chiral selector used in the Whelk-O I chiral stationary phase (CSP) was prepared and its scope evaluated. This chiral selector possesses a cleft flanked with aromatic groups and produces upfield chemical shifts for analytes. which are held in this cleft. The enantiomers of each of the Whelk-O I resolvable analytes surveyed show non-equivalent H-1 NMR spectra at room temperature with the addition of only 0.5 equiv of the CSA. Similar non-equivalence is sometimes noted for enantiomers, which do not resolve on this CSP. In such cases, it is apparent that a hydrogen bond acceptor is required and higher CSA to substrate ratios and/or lower temperatures may be needed if adequate resolution of enantiomeric signals is to be obtained. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2005.08.032
• 作为产物：
  描述：

  N-methyl-N-(4-methylphenyl)sulfonyl-3-phenylbutanamide 在 C₁₀H₈Na 作用下， 以 乙二醇二甲醚 为溶剂， 以53%的产率得到N-methyl-3-phenylbutanamide
  参考文献：
  名称：

  将有机铜试剂加到正甲苯基化的α，β-不饱和酰胺上

  摘要：

  N-甲苯磺酸化的α，β-不饱和酰胺和内酰胺与R 2 CuLi或RMgX / CuI（目录）轻松偶联。通过该方法可以实现反式-β，γ-二烷基-γ-内酰胺的立体选择性合成。通过还原或亲核取代，将所得的N-甲苯磺酰胺部分进一步转化为醇和几种羰基化合物。

  DOI：

  10.1016/s0040-4039(00)89172-8

文献信息

• [EN] SUBSTITUTED HETEROCYCLIC DERIVATIVES<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES SUBSTITUÉS
  申请人：HOFFMANN LA ROCHE

  公开号：WO2014079850A1

  公开（公告）日：2014-05-30

  The present invention relates to compounds of general formula (I-1) or (I-2) wherein R1 is hydrogen, lower alkyl, lower alkoxy, halogen, O(CH2)2-lower akoxy, O(CH2)2N(CH3)2, or O(CH2)-morpholinyl; R1' is hydrogen, lower alkyl, lower alkoxy, halogen, O(CH2)2-lower akoxy, O(CH2)2N(CH3)2, or O(CH2)-morpholinyl; with the proviso that both R1 and R1' may be simultaneously hydrogen, but only one of R1 and R1' is lower alkyl, lower alkoxy, halogen, O(CH2)2-lower akoxy, O(CH2)2N(CH3)2, or O(CH2)-morpholinyl; Het is a 5-or 6 membered heteroaryl group, wherein the heteroatom is selected from N, O or S; X is -CRR'-, -CRR'-NR'-, -C(O)-, -CH2-S-, -CH2-S(O)2-, CH2-O- or -CH2-CRR'-; R/R' are independently from each other hydrogen, lower alkyl, hydroxy or phenyl, or R and R' may form together with the carbon atom to which they are attached a cyclopropyl ring; R2 is lower alkyl, -C(O)O-lower alkyl, C3-6-cycloalkyl optionally substituted by lower alkyl or =O, bridged cyclohexyl or C3-6-cycloalkenyl, or is a 5-membered heteroaryl group, wherein the heteroatom is selected from N, O or S and which is optionally substituted by one or more lower alkyl, or is pyridinyl, optionally substituted by halogen or lower alkoxy; or is phenyl, optionally substituted by one or more R2', selected from halogen, cyano, S(O)2-lower alkyl, lower alkyl, lower alkyl substituted by halogen, lower alkoxy, lower alkoxy substituted by halogen or amino, or is benzo[1,3]dioxolyl, naphthyl, indolyl, benzo-isoxazolyl, 2,3-dihydro-1H-indenyl, optionally substituted by lower alkoxy or by an oxo group, or is 3,4-dihydro-2H- [1,4]oxazinyl, optionally substituted by an oxo group, or is a five or six membered heterocycloalkyl group; or to a pharmaceutically acceptable acid addition salt, to a racemic mixture or to its corresponding enantiomer and/or optical isomers thereof. The compounds may be used for the treatment or prophylaxis of schizophrenia, obsessive-compulsive personality disorder, major depression, bipolar disorders, anxiety disorders, normal aging, epilepsy, retinal degeneration, traumatic brain injury, spinal cord injury, post-traumatic stress disorder, panic disorder, Parkinson's disease, dementia, Alzheimer's disease, mild cognitive impairment, chemotherapy-induced cognitive dysfunction, Down syndrome, autism spectrum disorders, hearing loss, tinnitus, spinocerebellar ataxia, amyotrophic lateral sclerosis, multiple sclerosis, Huntington's disease, stroke, radiation therapy, chronic stress, abuse of neuro-active drugs, such as alcohol, opiates, methamphetamine, phencyclidine and cocaine.

  本发明涉及通式（I-1）或（I-2）的化合物，其中R1为氢、较低烷基、较低烷氧基、卤素、O(CH2)2-较低烷氧基、O(CH2)2N(CH3)2或O(CH2)-吗啡啉基；R1'为氢、较低烷基、较低烷氧基、卤素、O(CH2)2-较低烷氧基、O(CH2)2N(CH3)2或O(CH2)-吗啡啉基；但要注意，R1和R1'中两者同时为氢，但只有一个为较低烷基、较低烷氧基、卤素、O(CH2)2-较低烷氧基、O(CH2)2N(CH3)2或O(CH2)-吗啡啉基；Het为5或6元杂芳基团，其中杂原子选自N、O或S；X为-CRR'-、-CRR'-NR'-、-C(O)-、-CH2-S-、-CH2-S(O)2-、CH2-O-或-CH2-CRR'-；R/R'独立地为氢、较低烷基、羟基或苯基，或R和R'可与它们连接的碳原子共同形成环丙基环；R2为较低烷基、-C(O)O-较低烷基、C3-6-环烷基（可选择地被较低烷基或=O取代）、桥环己基或C3-6-环烯基，或为5元杂芳基团，其中杂原子选自N、O或S，可选择地被一个或多个较低烷基取代，或为吡啶基，可选择地被卤素或较低烷氧基取代；或为苯基，可选择地被一个或多个来自卤素、氰基、S(O)2-较低烷基、较低烷基、被卤素取代的较低烷基、较低烷氧基、被卤素取代的较低烷氧基或氨基的R2'取代基，或为苯并[1,3]二氧杂环己基、萘基、吲哚基、苯并异噁唑基、2,3-二氢-1H-茚基，可选择地被较低烷氧基或氧羟基取代，或为3,4-二氢-2H-[1,4]噁唑基，可选择地被氧羟基取代，或为五元或六元杂环烷基团；或为药学上可接受的酸盐，或为外消旋混合物，或为其相应的对映体和/或光学异构体。这些化合物可用于治疗或预防精神分裂症、强迫性人格障碍、重性抑郁症、双相障碍、焦虑障碍、正常衰老、癫痫、视网膜退化、创伤性脑损伤、脊髓损伤、创伤后应激障碍、恐慌障碍、帕金森病、痴呆症、阿尔茨海默病、轻度认知障碍、化疗诱导的认知功能障碍、唐氏综合征、自闭症谱系障碍、听力损失、耳鸣、脊髓小脑性共济失调、肌萎缩侧索硬化、多发性硬化、亨廷顿病、中风、放射治疗、慢性压力、滥用神经活性药物，如酒精、阿片类药物、甲基苯丙胺、芬太尼和可卡因。
• Synthetic Applications of the β-Lithiation of β-Aryl Secondary Amides:  Diastereoselective and Enantioselective Substitutions
  作者：Gary P. Lutz、Hua Du、Donald J. Gallagher、Peter Beak

  DOI：10.1021/jo952223r

  日期：1996.1.1

  The sequence of beta-lithiation and electrophilic substitution of beta-aryl secondary amides is reported. The lithiations occur regioselectively at the beta-position, and the resulting lithiated intermediates can be reacted with a wide range of electrophiles to give substituted products. Reactions of beta-lithiated amides bearing an alpha-substituent provide substituted products with high diastereoselectivity, Electrophilic substitutions of beta-lithiated N-methylamides in the presence of the chiral diamine (-)-sparteine provide highly enantioenriched products. The methodology is used to synthesize enantioenriched beta-aryl beta-substituted amides, acids, and lactones.
• NAGASHIMA, HIDEO;OZAKI, NOBUYASU;WASHIYAMA, MASAYOSHI;ITOH, KENJI, TETRAHEDRON LETT., 1985, 26, N 5, 657-660
  作者：NAGASHIMA, HIDEO、OZAKI, NOBUYASU、WASHIYAMA, MASAYOSHI、ITOH, KENJI

  DOI：——

  日期：——
• Multi-branched polymer, process for producing the same, and applications thereof
  申请人：Mitsui Chemicals, Inc.

  公开号：EP1457512B1

  公开（公告）日：2008-05-07
• US7795347B2
  申请人：——

  公开号：US7795347B2

  公开（公告）日：2010-09-14